
ZEVRA THERAPEUTICS INC
ZVRA · NASDAQ
Updated at 2026-10-14 08:52:42
- Today's High
- $11.33
- Today’s Low
- $10.24
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $11.39
- Previous Close
- $11.32
- Volume
- 509.03K
- Market Cap
- $569.87M
- P/E Ratio
- 11.44X
- EPS
- $0.96
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 101 FEDERAL STREET, BOSTON, MA, UNITED STATES, 02110
- Country
- US
- Listing Date
- 2015-04-16
- Fiscal Year End
- December
- Shares Outstanding
- 59.12M
- CIK
- 0001434647
- Website
- zevra.com
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company is headquartered in Celebration, Florida.
Financial Metrics
Revenue
2026-06-30
$39.66M
2026-03-31
$36.22M
2025-12-31
$34.12M
2025-09-30
$26.06M
Operating Expenses
2026-06-30
$21.36M
2026-03-31
$25.17M
2025-12-31
$23.29M
2025-09-30
$20.36M
Net Income
2026-06-30
$8.75M
2026-03-31
$37.89M
2025-12-31
$12.16M
2025-09-30
-$544K
Net Profit Margin
2026-06-30
22.06%
2026-03-31
104.61%
2025-12-31
35.64%
2025-09-30
-2.08%
Earnings Per Share
2026-06-30
$0.25
2026-03-31
$0.18
2025-12-31
$0.19
2025-09-30
$-0.01
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$13.15M
2026-03-31
$43.46M
2025-12-31
$14.97M
2025-09-30
$1.46M
Effective Tax Rate
2026-06-30
31.59%
2026-03-31
15.43%
2025-12-31
3.95%
2025-09-30
44.31%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $39.66M | $36.22M | $34.12M | $26.06M |
| Operating Expenses | $21.36M | $25.17M | $23.29M | $20.36M |
| Net Income | $8.75M | $37.89M | $12.16M | -$544K |
| Net Profit Margin | 22.06% | 104.61% | 35.64% | -2.08% |
| Earnings Per Share | $0.25 | $0.18 | $0.19 | $-0.01 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $13.15M | $43.46M | $14.97M | $1.46M |
| Effective Tax Rate | 31.59% | 15.43% | 3.95% | 44.31% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.